Journal of the American Medical Association
The Journal of the American Medical Association (JAMA) is a leading global medical journal.
Its editorial objectives include to "maintain the highest standards of editorial integrity independent of any special interests" and "to achieve the highest level of ethical medical journalism...". 
Three Strikes And ...
For the third time in two months, Catherine DeAngelis, the editor-in-chief of the Journal of the American Medical Association (JAMA), has been embarrassed by revelations that articles published in the journal have not included full disclosure by authors of their drug industry funding. The latest edition of JAMA includes a study which links severe migraines to heart attacks in women. "All six of the study's authors have done consulting work or received research funding from makers of treatments for migraines or heart-related problems," reported Lindsay Tanner for Associated Press. "Authors should always err on the side of full disclosure," DeAngelis wrote in a note to readers. The Center for Science in the Public Interest argues that journals should institute a three-year ban for non-disclosure and the penalty should apply to all publications involved in the International Committee of Medical Journal Editors. Last week, DeAngelis told (sub req'd) the Wall Street Journal she was against instituting a ban.
- Catherine D. DeAngelis, Editor-in-Chief
- Phil B. Fontanarosa, Executive Deputy Editor
- Richard M. Glass, Deputy Editor
- Drummond Rennie, Deputy Editor
- Margaret A. Winker, Deputy Editor
- Annette Flanagin, Managing Deputy Editor
- Frank F. Davidoff, Chair of Journal Oversight Committee
- Robert A. Musacchio, Publisher
Related SourceWatch articles
- American Medical Association
- Direct-to-consumer advertising: CanWest's Bid to Overturn Canada's Ban
- Drug industry
- International Committee of Medical Journal Editors
- Pharmaceutical Research and Manufacturers of America
- "Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment—Correction", JAMA. Vol. 296 No. 2, July 12, 2006, page 170.
- Annette Flanagin, Phil B. Fontanarosa and Catherine D. DeAngelis, "Update on JAMA's Conflict of Interest Policy", Journal of the American Medical Association, Vol. 296 No. 2, July 12, 2006, pages 220-221.
- Lindsey Tanner, "Medical Journal Says It Was Again Misled", New York Times, July 13, 2006, Page A19. (This is an Associated Press story).
- Lindsey Tanner, "JAMA says docs misled over industry ties", Houston Chronicle, July 19, 2006. (This is an Associated Press Press story).
|This article is a stub. You can help by expanding it.|